Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001387131-19-005158
Filing Date
2019-07-17
Accepted
2019-07-17 17:26:17
Documents
3
Period of Report
2019-07-12
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K nbse-8ka_071219.htm 8-K/A 30742
2 OFFER OF EMPLOYMENT, DATED JULY 11, 2019 ex10-1.htm EX-10.1 42151
3 GRAPHIC neubase-logo.jpg GRAPHIC 11598
  Complete submission text file 0001387131-19-005158.txt   90452
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 001-35963 | Film No.: 19959822
SIC: 2834 Pharmaceutical Preparations